Cargando…

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening

BACKGROUND: According to international guidelines, HPV DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more severe lesions. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacobellis, Michela, Violante, Cecilia, Notarachille, Gabriella, Simone, Angela, Scarfì, Rosa, Giuffrè, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859641/ https://www.ncbi.nlm.nih.gov/pubmed/29558950 http://dx.doi.org/10.1186/s12985-018-0965-z

Ejemplares similares

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
por: Gustavsson, Inger, et al.
Publicado: (2019)

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening
por: Zhang, Wei, et al.
Publicado: (2020)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2022)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening
por: Akbari, Ajmal, et al.
Publicado: (2018)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
por: Di Bonito, Paola, et al.
Publicado: (2006)

Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
por: Lorenzi, Adriana T., et al.
Publicado: (2015)

Natural transformation of Thermotoga sp. strain RQ7
por: Han, Dongmei, et al.
Publicado: (2014)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

Matrix factorization for the reconstruction of cervical cancer screening histories and prediction of future screening results
por: Langberg, Geir Severin R. E., et al.
Publicado: (2022)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Expression of Heterologous Cellulases in Thermotoga sp. Strain RQ2
por: Xu, Hui, et al.
Publicado: (2015)

Complete genome sequence of Thermotoga sp. strain RQ7
por: Xu, Zhaohui, et al.
Publicado: (2017)

RQ Labs: A Cybersecurity Workforce Skills Development Framework
por: Daniel, Clinton, et al.
Publicado: (2022)

Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
por: Branković, Ivan, et al.
Publicado: (2013)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

On-line optimization of glutamate production based on balanced metabolic control by RQ
por: Xiao, Jie, et al.
Publicado: (2006)

Complete genome sequence of Truepera radiovictrix type strain (RQ-24(T))
por: Ivanova, Natalia, et al.
Publicado: (2011)

Protective effect of the AT(137)RQ and ARQK(176) PrP alleles against classical scrapie in Sarda breed sheep
por: Vaccari, Gabriele, et al.
Publicado: (2009)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
por: Ma, Zhihai, et al.
Publicado: (2022)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Antidepressive effect of an inward rectifier K(+) channel blocker peptide, tertiapin-RQ
por: Okada, Masayoshi, et al.
Publicado: (2020)

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
por: Engesæter, Birgit, et al.
Publicado: (2016)

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
por: Ogilvie, Gina S, et al.
Publicado: (2010)

Testing positive for Human Papillomavirus (HPV) at primary HPV cervical screening: A qualitative exploration of women’s information needs and preferences for communication of results
por: Mulcahy Symmons, Sophie, et al.
Publicado: (2021)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Adapted laboratory evolution of Thermotoga sp. strain RQ7 under carbon starvation
por: Gautam, Jyotshana, et al.
Publicado: (2022)

Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
por: Senkomago, Virginia, et al.
Publicado: (2016)

HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
por: Kantathavorn, Nuttavut, et al.
Publicado: (2015)

Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping
por: Padhy, Radha Rani, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5de5vltn8bqtkgrnd903he9oao